vimarsana.com
Home
Live Updates
Exai Bio's RNA- and AI-based Liquid Biopsy Platform Detects
Exai Bio's RNA- and AI-based Liquid Biopsy Platform Detects
Exai Bio's RNA- and AI-based Liquid Biopsy Platform Detects Early Stage Breast Cancer with High Accuracy, Overcoming Many Limitations of DNA-based Approaches | Region
PALO ALTO, Calif.--(BUSINESS WIRE)--Dec 6, 2023--
Related Keywords
California ,
United States ,
Jieyang ,
Guangdong ,
China ,
Kim Maxwell Brown ,
Jeffrey Wang ,
Exai Bio ,
Pat Arensdorf ,
Linkedin ,
Twitter ,
San Antonio Breast Cancer Symposium ,
Chief Executive Officer ,
Spotlight Session ,
Poster Session ,
Jieyang Wang ,
Kim Maxwell ,
Business Wire ,
Region ,